389 related articles for article (PubMed ID: 176177)
1. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
Carson DA; Seegmiller JE
J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
[TBL] [Abstract][Full Text] [Related]
2. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.
Snyder FF; Mendelsohn J; Seegmiller JE
J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393
[TBL] [Abstract][Full Text] [Related]
3. In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.
Magnuson NS; Perryman LE
J Clin Invest; 1979 Jul; 64(1):89-101. PubMed ID: 447864
[TBL] [Abstract][Full Text] [Related]
4. Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin.
Smith JW; Steiner AL; Parker CW
J Clin Invest; 1971 Feb; 50(2):442-8. PubMed ID: 4322078
[TBL] [Abstract][Full Text] [Related]
5. Role of adenosine deaminase in lymphocyte proliferation.
Hovi T; Smyth JF; Allison AC; Williams SC
Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts.
Snyder FF; Hershfield MS; Seegmiller JE
Cancer Res; 1978 Aug; 38(8):2357-62. PubMed ID: 667833
[TBL] [Abstract][Full Text] [Related]
7. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
Ullman B; Cohen A; Martin DW
Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
[TBL] [Abstract][Full Text] [Related]
9. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
Haynes J; Killilea DW; Peterson PD; Thompson WJ
J Pharmacol Exp Ther; 1996 Feb; 276(2):752-7. PubMed ID: 8632346
[TBL] [Abstract][Full Text] [Related]
10. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells.
Smolenski RT; Kalsi KK; Zych M; Kochan Z; Yacoub MH
J Mol Cell Cardiol; 1998 Mar; 30(3):673-83. PubMed ID: 9515042
[TBL] [Abstract][Full Text] [Related]
11. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
Thuillier L; Garreau F; Cartier PH
Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
[TBL] [Abstract][Full Text] [Related]
12. Biochemical aspects of cardiac muscle differentiation. Possible control of deoxyribonucleic acid synthesis and cell differentiation by adrenergic innervation and cyclic adenosine 3':5'-monophosphate.
Claycomb WC
J Biol Chem; 1976 Oct; 251(19):6082-9. PubMed ID: 184091
[TBL] [Abstract][Full Text] [Related]
13. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
14. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
Goday A; Simmonds HA; Webster DR; Morris GS
Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipolysis and cyclic AMP accumulation in white fat cells by tetracycline.
Madison KC; Fain JN
Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):224-31. PubMed ID: 168821
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the in vitro early anamnestic antibody response by exogenous cholera enterotoxin and cyclic AMP.
Cook RG; Stavitsky AB; Schoenberg MD
J Immunol; 1975 Jan; 114(1 Pt 2):426-34. PubMed ID: 163858
[TBL] [Abstract][Full Text] [Related]
17. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
Méry PF; Pavoine C; Pecker F; Fischmeister R
Mol Pharmacol; 1995 Jul; 48(1):121-30. PubMed ID: 7623766
[TBL] [Abstract][Full Text] [Related]
18. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
Veit BC; Fishman M; Look T
J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors.
Barankiewicz J; Danks AM; Abushanab E; Makings L; Wiemann T; Wallis RA; Pragnacharyulu PV; Fox A; Marangos PJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1230-8. PubMed ID: 9399998
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera.
Hargrove JL; Granner DK
J Cell Physiol; 1982 Jun; 111(3):232-8. PubMed ID: 6124549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
